Back to search results

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Abroad (travel likely)Recruiting

Conditions

Aortic Stenosis Treated With TAVI · Aortic Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • NCH Baker Hospital-Naples Heart Institute, Naples, Florida, United States

    Contact: Study coordinator (Kathy Byrd) · (239)624-8113
    Contact: Principal Investigator (Robert Cubeddu)

  • St. Vincent Hospital, Indianappolis, Indiana, United States

    Contact: Study coordinator (Kelly Verel) · kelly.verel@ascension.org · 317-338-8042
    Contact: Principal Investigator (James Hermiller, MD)

  • Henry Ford Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Stephen Krafchak) · skrafch1@hfhs.org · 313-972-4018
    Contact: Study coordinator (Sara Poggio, RN) · spoggio1@hfhs.org · 313-916-0119
    Contact: Principal Investigator (Brian O'Neill, MD)

  • St. Lukes Hospital Of Kansas City, Kansas City, Missouri, United States

    Contact: Study coordinator (Caroline Kempter) · ckempter@saint-lukes.org
    Contact: Study coordinator (Anne Hoffman) · ahoffman@saint-lukes.org · 816-932-5707

  • Cumc/Nyph, New York, New York, United States

    Contact: Study coordinator (Kate Dalton) · keb2114@columbia.edu · 212-342-1820
    Contact: Study coordinator (Treena Williams) · taw2112@columbia.edu
    Contact: Principal Investigator (Torsten Vahl, MD)

  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

    Contact: Study coordinator (Emily Tylicki) · TYLICKE@ccf.org · 216-287-8237
    Contact: Principal Investigator (Amar Krishnaswamy, MD)

  • Ohio Health Research Institute (aka Riverside Methodist Hospital), Columbus, Ohio, United States

    Contact: Study coordinator (Maureen McCormack) · Maureen.McCormack@ohiohealth.com · (614) 788-3885
    Contact: Study coordinator (Christina Belcher) · christina.belcher@ohiohealth.com · 614-813-4555
    Contact: Principal Investigator (Steven Yakubov, MD)

  • University of Virginia Medical Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Linda Bailes Bryceland) · LGS2M@uvahealth.org · 434-982-1058
    Contact: Principal Investigator (John Saxon)

  • St Andrews War Memorial Hospital, Spring Hill, Queensland, Australia

    Contact: Study coordinator (Linda Pearce) · linda.pearce@wesleyresearch.org.au
    Contact: Principal Investigator (Karl Poon, MD)

  • Monash Health Public, Clayton, Victoria, Australia

    Contact: Study coordinator (Trazzie Luk) · TszTing.Luk@monashhealth.org
    Contact: Principal Investigator (Robert Gooley, MD)
View source on ClinicalTrials.gov(opens in a new tab)